| 2023 | Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonal- coholic fatty liver disease: A network meta-analysis | 김명규 | Article |
| 2022 | Discovery of dipeptidyl peptidase-4 inhibitor specific biomarker in non-alcoholic fatty liver disease mouse models using modified basket trial | 김완규 | Article |
| 2023 | Effect of 12-week intermittent calorie restriction compared to standard of care in patients with nonalcoholic fatty liver disease: a randomized controlled trial | 김유리; 김휘영; 이혜아; 이한아 | Article |
| 2022 | Exercise reduces the risk of chronic kidney disease in individuals with nonalcoholic fatty liver disease: A nationwide cohort study | 이민종; 전호수 | Article |
| 2015 | Ezetimibe improves hepatic steatosis in relation to autophagy in obese and diabetic rats | 장유진 | Article |
| 2021 | Glycemic variability and the risk of nonalcoholic fatty liver disease : A nationwide population-based cohort study | 홍소현 | Article |
| 2019 | Integrative omics reveals metabolic and transcriptomic alteration of nonalcoholic fatty liver disease in catalase knockout mice | 하헌주 | Article |
| 2023 | Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future | 이한아 | Review |
| 2020 | Noninvasive indices for predicting nonalcoholic fatty liver disease in patients with chronic kidney disease | 유권; 이정경; 김태헌; 류동열; 김휘영; 임지영; 김진실; 이혜아 | Article |
| 2021 | The fib-4 index is a useful predictor for the development of hepatocellular carcinoma in patients with coexisting nonalcoholic fatty liver disease and chronic hepatitis b | 이민종 | Article |
| 2022 | Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases | 이한아 | Review |
